comparemela.com

Latest Breaking News On - Travis bond - Page 4 : comparemela.com

Altoida Selected as a Featured Innovator at LSI 2022 Medtech Investor Summit

/PRNewswire/ Altoida, Inc. an artificial intelligence (AI) company pioneering next-generation neurological disease diagnostics and brain health solutions,.

United statesScott pantelTravis bondAltoida incGn groupDevice designationMild cognitive impairmentClick therapeuticsEmerging medtech summitEisai innovationHikma venturesGreysky venture partnersAlpana venturesSouthern californiaLife science intelligence

Altoida Selected as a Featured Innovator at LSI 2022 Medtech Investor Summit

/PRNewswire/ Altoida, Inc. an artificial intelligence (AI) company pioneering next-generation neurological disease diagnostics and brain health solutions,.

United statesScott pantelTravis bondAltoida incGn groupDevice designationMild cognitive impairmentClick therapeuticsEmerging medtech summitEisai innovationHikma venturesGreysky venture partnersAlpana venturesSouthern californiaLife science intelligence

LIFE SCIENCE INTELLIGENCE (LSI) USA 2022 EMERGING MEDTECH SUMMIT IS OPEN FOR IN PERSON AND VIRTUAL REGISTRATION

DANA POINT, Calif., Jan. 26, 2022 /PRNewswire/ In March 2022, Over 150 presenting Medtech startup companies and over 100 investors will come to.

United statesDana pointPierre alexandre fournierMatt ahearnBryce klontzTravis bondKyle dempseyValavanur mani subramanianAdam sachsLife science intelligenceMonarch beach resortHexoskin smartNew viewHeart repairShoulder innovationsMedtech summit

LIFE SCIENCE INTELLIGENCE (LSI) USA 2022 EMERGING MEDTECH SUMMIT IS OPEN FOR IN PERSON AND VIRTUAL REGISTRATION

/PRNewswire/ In March 2022, Over 150 presenting Medtech startup companies and over 100 investors will come together for the third annual Life Science.

United statesDana pointPierre alexandre fournierMatt ahearnBryce klontzTravis bondKyle dempseyValavanur mani subramanianAdam sachsLife science intelligenceMonarch beach resortHexoskin smartNew viewHeart repairShoulder innovationsMedtech summit

ProMIS Neurosciences to Participate in the Biotech Showcase 2022 Virtual Panel Discussion: Aduhelm Stimulating the Next Generation of Alzheimer s Treatment

07.01.2022 - TORONTO, Ontario and CAMBRIDGE, Mass., Jan. 07, 2022 (GLOBE NEWSWIRE) - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins .

United kingdomUnited statesMichael mcfaddenBrent vaughanLisa ricciardiTravis bondEugene williamsPhyllis barkman ferrellNicholas rigopulosEli lilly companyPromis neurosciences incAltoida incToronto stock exchangeCognition therapeutics incAlpha cognition incGlobal head

vimarsana © 2020. All Rights Reserved.